Metrics
- Price
- $65.25
- Market Cap $M
- 5,803
- Rel Volume
- 1.47
- Vol Up 2W
- 66.7%
- Vol Trend 2W
- +149.8%
- 1D
- +1.9%
- 1W
- +4.3%
- 1M
- +15.3%
- 1M Slope
- +9.4%
- 6M Range
- 117.5%
- Score
- 87.9
- Sharp
- 10.3
Volume
Profile
Liquidia develops inhaled therapies for serious pulmonary diseases, including an approved treatment for pulmonary arterial hypertension and a pipeline of respiratory drug candidates.
Healthcare
Pharmaceuticals
Biotech